LEMAITRE VASCULAR INC (LMAT)
US5255582018 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to LMAT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 70.51. This target is 8.31% above the current price.
LMAT was analyzed by 15 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LMAT.
In the previous month the buy percentage consensus was at a similar level.
LMAT was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-26 | Stifel | Upgrade | Hold -> Buy |
| 2024-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-06 | Keybanc | Initiate | Sector Weight |
| 2023-10-23 | JMP Securities | Initiate | Market Outperform |
| 2023-09-06 | Oppenheimer | Initiate | Outperform |
| 2023-08-03 | Jefferies | Downgrade | Buy -> Hold |
| 2023-08-02 | Lake Street | Maintains | Buy -> Buy |
| 2023-08-02 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-05-03 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2022-10-28 | Barrington Research | Downgrade | Outperform -> Market Perform |
| 2021-09-16 | Jefferies | Initiate | Buy |
| 2021-08-03 | Roth Capital | Maintains | Neutral |
| 2021-05-04 | Roth Capital | Maintains | Neutral |
| 2021-02-12 | Keybanc | Initiate | Sector Weight |